• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Exacerbating the burden of cardiovascular disease: how can we address cardiopulmonary risk in individuals with chronic obstructive pulmonary disease?

作者信息

Shrikrishna Dinesh, Taylor Clare J, Stonham Carol, Gale Chris P

机构信息

Department of Respiratory Medicine, Musgrove Park Hospital, Somerset NHS Foundation Trust, Parkfield Drive, Taunton TA1 5DA, UK.

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

出版信息

Eur Heart J. 2024 Jan 27;45(4):247-249. doi: 10.1093/eurheartj/ehad669.

DOI:10.1093/eurheartj/ehad669
PMID:37832033
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10821359/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da0d/10821359/2784ee7c1118/ehad669f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da0d/10821359/2784ee7c1118/ehad669f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da0d/10821359/2784ee7c1118/ehad669f1.jpg

相似文献

1
Exacerbating the burden of cardiovascular disease: how can we address cardiopulmonary risk in individuals with chronic obstructive pulmonary disease?加重心血管疾病负担：我们如何应对慢性阻塞性肺疾病患者的心肺风险？
Eur Heart J. 2024 Jan 27;45(4):247-249. doi: 10.1093/eurheartj/ehad669.
2
Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review.心肺风险对 COPD 管理的影响：叙事性综述。
Adv Ther. 2024 Jun;41(6):2151-2167. doi: 10.1007/s12325-024-02855-4. Epub 2024 Apr 25.
3
Inhaled tiotropium to prevent postoperative cardiopulmonary complications in patients with newly diagnosed chronic obstructive pulmonary disease requiring lung cancer surgery.吸入噻托溴铵预防新诊断的需要肺癌手术的慢性阻塞性肺疾病患者术后心肺并发症。
Surg Today. 2014 Feb;44(2):285-90. doi: 10.1007/s00595-012-0481-5. Epub 2013 Jan 10.
4
[Chronic obstructive pulmonary disease and cardiovascular disease].[慢性阻塞性肺疾病与心血管疾病]
Arch Bronconeumol. 2010;46 Suppl 3:18-22. doi: 10.1016/S0300-2896(10)70022-3. Epub 2010 Jun 20.
5
[Cardiopulmonary interactions: cardiovascular diseases and chronic obstructive pulmonary disease].[心肺相互作用：心血管疾病与慢性阻塞性肺疾病]
Dtsch Med Wochenschr. 2009 Apr;134(16):818-22. doi: 10.1055/s-0029-1220237. Epub 2009 Apr 7.
6
Comorbidities and systemic effects of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的合并症及全身影响。
Clin Chest Med. 2014 Mar;35(1):101-30. doi: 10.1016/j.ccm.2013.10.007.
7
COPD may limit your heart function. Restricted air flow forces your heart to work harder, but treatments can ease the burden.慢性阻塞性肺疾病（COPD）可能会限制你的心脏功能。气流受限会迫使你的心脏更加努力地工作，但治疗可以减轻负担。
Heart Advis. 2010 Apr;13(4):1, 7.
8
Cardiovascular injury and repair in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的心血管损伤与修复
Proc Am Thorac Soc. 2008 Dec 1;5(8):824-33. doi: 10.1513/pats.200807-071TH.
9
Increased risk for cardiovascular disease in patients with obstructive sleep apnoea syndrome-chronic obstructive pulmonary disease (overlap syndrome).阻塞性睡眠呼吸暂停低通气综合征合并慢性阻塞性肺疾病（重叠综合征）患者心血管疾病风险增加。
Clin Respir J. 2019 Nov;13(11):708-715. doi: 10.1111/crj.13078. Epub 2019 Sep 8.
10
AECOPD: Acute exacerbations of chronic obstructive cardiopulmonary disease?慢性阻塞性心肺疾病急性加重？
Am J Respir Crit Care Med. 2013 Nov 1;188(9):1046-8. doi: 10.1164/rccm.201309-1651ED.

引用本文的文献

1
Chronic Obstructive Pulmonary Disease and the Management of Cardiopulmonary Risk in the UK: A Systematic Literature Review and Modified Delphi Study.慢性阻塞性肺疾病与英国心肺风险的管理：一项系统文献综述及改良德尔菲研究
Int J Chron Obstruct Pulmon Dis. 2025 Jun 25;20:2073-2090. doi: 10.2147/COPD.S523865. eCollection 2025.
2
Prevalence and Impact of Chronic Obstructive Pulmonary Disease in Ischemic Heart Disease: A Systematic Review and Meta-Analysis of 18 Million Patients.慢性阻塞性肺疾病在缺血性心脏病患者中的患病率和影响：一项纳入 1800 万患者的系统评价和荟萃分析。
Int J Chron Obstruct Pulmon Dis. 2024 Oct 22;19:2333-2345. doi: 10.2147/COPD.S474223. eCollection 2024.
3

本文引用的文献

1
Sex-specific and age-specific incidence of ischaemic heart disease, atrial fibrillation and heart failure in community patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病社区患者中缺血性心脏病、心房颤动和心力衰竭的性别特异性和年龄特异性发病率。
BMJ Open Respir Res. 2022 Dec;9(1). doi: 10.1136/bmjresp-2022-001307.
2
Mortality Risk and Serious Cardiopulmonary Events in Moderate-to-Severe COPD: Post Hoc Analysis of the IMPACT Trial.中度至重度慢性阻塞性肺疾病的死亡风险和严重心肺事件：IMPACT试验的事后分析
Chronic Obstr Pulm Dis. 2023 Jan 25;10(1):33-45. doi: 10.15326/jcopdf.2022.0332.
3
Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission.
Cardiovascular Risk in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review.
慢性阻塞性肺疾病患者的心血管风险：一项系统评价
J Clin Med. 2024 Aug 31;13(17):5173. doi: 10.3390/jcm13175173.
4
Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review.心肺风险对 COPD 管理的影响：叙事性综述。
Adv Ther. 2024 Jun;41(6):2151-2167. doi: 10.1007/s12325-024-02855-4. Epub 2024 Apr 25.
5
Time Trend Analysis of Comorbidities in Ankylosing Spondylitis: A Population-Based Study from 53,142 Hospitalizations in Poland.强直性脊柱炎合并症的时间趋势分析：一项基于波兰53142例住院病例的人群研究。
J Clin Med. 2024 Jan 21;13(2):602. doi: 10.3390/jcm13020602.
迈向消除慢性阻塞性肺疾病：柳叶刀委员会报告。
Lancet. 2022 Sep 17;400(10356):921-972. doi: 10.1016/S0140-6736(22)01273-9. Epub 2022 Sep 5.
4
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study.ETHOS 研究中布地奈德/格隆溴铵/福莫特罗治疗慢性阻塞性肺疾病降低全因死亡率：一项随机、双盲、多中心、平行分组研究。
Am J Respir Crit Care Med. 2021 Mar 1;203(5):553-564. doi: 10.1164/rccm.202006-2618OC.
5
Management and Risk of Mortality in Patients Hospitalised Due to a First Severe COPD Exacerbation.首次因重度慢性阻塞性肺疾病急性加重住院患者的管理与死亡风险
Int J Chron Obstruct Pulmon Dis. 2020 Oct 28;15:2673-2682. doi: 10.2147/COPD.S276819. eCollection 2020.
6
Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial.慢性阻塞性肺疾病恶化和心脏事件。SUMMIT 随机临床试验的事后队列分析。
Am J Respir Crit Care Med. 2018 Jul 1;198(1):51-57. doi: 10.1164/rccm.201711-2239OC.
7
Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.欧洲心脏病学会心力衰竭长期注册研究中因慢性阻塞性肺疾病住院和门诊心力衰竭患者的特征、治疗和 1 年预后。
Eur J Heart Fail. 2018 Jan;20(1):100-110. doi: 10.1002/ejhf.964. Epub 2017 Sep 26.
8
Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort.ECLIPSE 队列中的合并症、全身炎症与结局。
Respir Med. 2013 Sep;107(9):1376-84. doi: 10.1016/j.rmed.2013.05.001. Epub 2013 Jun 19.
9
Increased risk of myocardial infarction and stroke following exacerbation of COPD.COPD 加重后心肌梗死和中风风险增加。
Chest. 2010 May;137(5):1091-7. doi: 10.1378/chest.09-2029. Epub 2009 Dec 18.